FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
15 letters match. Newest first.
-
BiologicsConceive Fertility Center
FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.
High risk -
BiologicsLouisville Reproductive Center
Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.
High risk -
BiologicsGreen Valley Fertility Partners
FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.
High risk -
BiologicsMicrovascular Tissue, Inc.
FDA says Microvascular Tissue's mVASC wound product is an unapproved drug and unlicensed biologic, made without validated processes.
High risk -
BiologicsNuVida Medical LLC
FDA says NuVida Medical sells unapproved, unlicensed tissue products for non-homologous wound care uses.
High risk -
BiologicsInVia Fertility Specialists, PLLC
FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.
High risk -
BiologicsSkye Biologics Holdings LLC
FDA warns Skye Biologics its umbilical cord-derived BioECM products are unapproved drugs and unlicensed biologics, made with serious manufacturing (CGMP) failures.
High risk -
BiologicsFrontier Biologics, LLC
FDA warned Frontier Biologics of Waco, Texas, that its amniotic fluid and membrane products are unapproved drugs and unlicensed biologics.
High risk -
BiologicsBerkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.
FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.
High risk -
BiologicsNew Mexico Lions Sight Conservation Foundation, Inc. dba New Mexico Lions Eye Bank
FDA warns New Mexico eye bank over distributing eye tissue from two donors with sepsis.
High risk -
BiologicsIndiana Lions Eye Bank, Inc. dba VisionFirst Indiana Lions Eye Bank
Indiana Lions Eye Bank distributed ocular tissue from donors with sepsis after failing to screen them as ineligible.
High risk -
BiologicsCryos International USA LLC
Cryos International USA released and distributed anonymous donor semen without required infectious disease testing and quarantine.
High risk -
BiologicsZhang Medical P.C. dba New Hope Fertility Center
New Hope Fertility Center failed to properly screen and test oocyte and semen donors for communicable diseases, FDA says.
High risk -
BiologicsOsteoLife Biomedical I LLC
FDA warned OsteoLife Biomedical over unvalidated processing and microbial contamination of human bone tissue products, including distributed batches.
High risk -
BiologicsUtah Cord Bank LLC dba Utah Cell Bank
Utah Cell Bank made unapproved injectable stem cell products and fell short on sterility and manufacturing controls, FDA found.
High risk